BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6289038)

  • 1. [Symptomology of non-invasive proliferative epithelial changes in the breast].
    Geppert M; Bachmann FF
    Med Welt; 1982 Jul; 33(28):1020-3. PubMed ID: 6289038
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pre-invasive tumors and precancerous conditions of the breast: pathologico-anatomic demarcation and clinical consequences].
    Bässler R; Werner J
    Chirurg; 1984 Mar; 55(3):133-41. PubMed ID: 6325099
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
    Mehtani VG; Joshi K; Mehrotra GC
    Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunocytochemical demonstration of actin in myothelial cells in proliferative diseases of the breast].
    Walther B; Rutter G; Stegner HE; Böcker W
    Pathologe; 1986 Nov; 7(6):318-23. PubMed ID: 3027685
    [No Abstract]   [Full Text] [Related]  

  • 5. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 7. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunohistochemical breast cancer diagnosis].
    Schauer A; Brehler R; Bergholz M
    Verh Dtsch Ges Pathol; 1985; 69():171-86. PubMed ID: 2420086
    [No Abstract]   [Full Text] [Related]  

  • 9. [Significance of hyperelastosis in proliferative lesions of the breast].
    Cuccurullo L; Giordano GG; Mineo A; Iaccarino M; Battista O; Cattaneo L; Ferraraccio F
    Pathologica; 1984; 76(1041):89-101. PubMed ID: 6087264
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anatomo-pathologic considerations on the subject of minimal carcinoma of the breast].
    Zampi G; Bianchi S; Amorosi A
    Minerva Chir; 1989 Feb; 44(3):419-21. PubMed ID: 2541375
    [No Abstract]   [Full Text] [Related]  

  • 11. [CEA, grade and stage in breast carcinoma. Immunohistochemical study of 40 cases].
    Sironi M; Cantaboni A
    Pathologica; 1984; 76(1044):427-36. PubMed ID: 6096797
    [No Abstract]   [Full Text] [Related]  

  • 12. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 13. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histo-prognostic elements in breast cancer].
    Jacquemier J; Bonneau HP
    J Gynecol Obstet Biol Reprod (Paris); 1978 Mar; 7(2):200-8. PubMed ID: 209077
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical implications of preinvasive and small invasive breast carcinomas.
    Rosen PP
    Pathol Annu; 1981; 16(Pt 2):337-56. PubMed ID: 6276848
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
    Haase W
    Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperplastic lesions of the human breast: scanning electron microscopy and a review of current knowledge.
    Halter SA; Holt DH; Page DL
    Scan Electron Microsc; 1981; (Pt 3):11-21. PubMed ID: 6276966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytological changes in breast carcinoma in situ].
    Stosiek U; Breitbach GP
    Zentralbl Gynakol; 1984; 106(6):407-10. PubMed ID: 6326431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lobular neoplasm arising in a fibroadenoma. Clinical case report].
    Leuzzi R; Barillari P; Bianco C; Caruso L; Ranieri E; Virno F
    Minerva Chir; 1988 Jun; 43(12):1099-101. PubMed ID: 2845301
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.